FREE SHIPPING ON ORDERS OVER $100 WITHIN THE CONTIGUOUS US

Balance Sheet

v3.22.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Feb. 28, 2022
Nov. 30, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 44,701 $ 56,308
Restricted cash 0 92
Accounts receivable, net 1,101 1,658
Inventory, net 12,072 6,613
Prepaid expenses and other current assets 1,934 1,490
Total current assets 59,808 66,161
LONG TERM ASSETS    
Patent rights, net 3,612 3,668
Deposits for equipment 2,046 1,293
Right-of-use asset, net 1,444 1,086
Property and equipment, net 2,043 1,972
Goodwill 816 816
Other assets 727 318
TOTAL ASSETS 70,496 75,314
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 6,744 6,996
Operating lease liabilities, current 498 463
Deferred revenue, current 361 720
Total current liabilities 7,603 8,179
LONG TERM LIABILITIES    
Deferred revenue - non-current 415 405
Operating lease liabilities, non-current 1,071 632
Total liabilities 9,089 9,216
COMMITMENTS AND CONTINGENCIES (NOTE 21)
STOCKHOLDERS’ EQUITY    
Preferred stock 0 0
Common stock, $0.001 par value, 300,000,000 shares authorized. 23,960,588 shares issued and 23,664,369 outstanding as of February 28, 2022 and, 23,754,096 shares issued and outstanding as of November 30, 2021 23 23
Additional paid-in capital 120,767 119,589
Treasury stock (296,168 and 0 shares purchased, respectively) (2,654) 0
Accumulated deficit (56,719) (53,498)
Accumulated other comprehensive loss (10) (16)
Total Stockholders’ Equity 61,407 66,098
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 70,496 75,314
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock $ 0 $ 0

Source